Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Accured Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Precigen (PGEN) Notes Payables (2022 - 2023)

Precigen (PGEN) has disclosed Notes Payables for 2 consecutive years, with $13.8 million as the latest value for Q1 2023.

On a quarterly basis, Notes Payables changed N/A to $13.8 million in Q1 2023 year-over-year; TTM through Mar 2023 was $13.8 million, a N/A change, with the full-year FY2022 number at $43.2 million, changed N/A from a year prior.
Notes Payables was $13.8 million for Q1 2023 at Precigen, down from $43.2 million in the prior quarter.
In the past five years, Notes Payables ranged from a high of $43.2 million in Q4 2022 to a low of $13.8 million in Q1 2023.